Guanine analog-induced differentiation of human promyelocytic leukemia cells and changes in queuine modification of tRNA.

AUTOR(ES)

Kretz, K A

RESUMO

Treatment of hypoxanthine-guanine phosphoribosyltransferase (HGPRT)-deficient human promyelocytic leukemia (HL-60) cells with 6-thioguanine results in growth inhibition and cell differentiation. 6-Thioguanine is a substrate for the tRNA modification enzyme tRNA-guanine ribosyltransferase, which normally catalyzes the exchange of queuine for guanine in position 1 of the anticodon of tRNAs for asparagine, aspartic acid, histidine, and tyrosine. During the early stages of HGPRT-deficient HL-60 cell differentiation induced by 6-thioguanine, there was a transient decrease in the queuine content of tRNA, and changes in the isoacceptor profiles of tRNA(His) indicate that 6-thioguanine was incorporated into the tRNA in place of queuine. Reversing this structural change in the tRNA anticodon by addition of excess exogenous queuine reversed the 6-thioguanine-induced growth inhibition and differentiation. Similar results were obtained when 8-azaguanine (another inhibitor of queuine modification of tRNA that can be incorporated into the anticodon) replaced 6-thioguanine as the inducing agent. The data suggest a primary role for the change in queuine modification of tRNA in mediating the differentiation of HGPRT-deficient HL-60 cells induced by guanine analogs.

Documentos Relacionados

• Involvement of protein kinase C in the control of tRNA modification with queuine in HeLa cells.
• Chorismic acid, a key metabolite in modification of tRNA.
• Aminoacyl-tRNA synthetase-induced cleavage of tRNA.
• Studies on human tRNA. I. The rapid, large scale isolation and partial fractionation of placenta and liver tRNA.
• From elongator tRNA to initiator tRNA.